Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Actusnews Wire
504 Leser
Artikel bewerten:
(2)

VISIOMED GROUP: Visiomed Group reaches a major milestone and confirms its ambition to be the leader in advanced medical centers by setting up in Saudi Arabia.

Finanznachrichten News

Paris, January 2, 2024

VISIOMED GROUP (FR0013481835 - ALVMG), a group dedicated to innovative healthcare technologies and services, announces a strategic milestone in the deployment of its activities in Saudi Arabia. The Group, via its subsidiary Smart Health, has just secured a prime location for its 1st medical center of over 600 square meters in the heart of Riyadh's dynamic financial district: King Abdullah Financial District (KAFD).

The new center will offer the Group's unique know-how, already deployed in the Smart Salem centers in Dubai, combining technology, speed of patient data processing and medical expertise. Patients will benefit from an ultra-fast, fully digitized screening service for administrative medical tests, as well as a range of state-of-the-art health and prevention check-ups.

As an illustration of the Kingdom's development policy, KAFD is a booming business center, home to major Saudi public and private entities, as well as a wide range of major international companies, which are choosing Saudi Arabia and KAFD as their new regional headquarters. The KAFD area is already well occupied, and building extensions are underway to accommodate more companies, as well as developing commercial and residential areas.

Riyadh is home to a population of almost 7 million people. 60% of Riyadh's population is within 25 minutes of KAFD, 85% within 35 minutes. 3 metro lines also connect KAFD to Riyadh International Airport, with a journey time of 20 minutes.

"We had announced our ambition to replicate our success in Dubai by setting up in Saudi Arabia in order to strengthen our position as leader in digitalized medical centers and considerably expand our addressable market. With this privileged location in the heart of an area representing the dynamism of Saudi Arabia, we are in the best conditions to develop rapidly", said Guillaume Bremond, Chairman of Visiomed.

Smart Health will now finalize the design phase of the new center, prior to the start of construction. The investment and financing methods envisaged are comparable to those the Group has already successfully implemented in Dubai for the Smart Salem centers. The center is scheduled to open in 2024.

***

About VISIOMED GROUP

Founded in 2007, VISIOMED GROUP relies on a long experience in the health sector to invest in innovative health technologies and services in France and abroad.

The Group now has focused its activities on the Middle East since 2021 and the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group.

Visiomed is also accelerating its development in the region with the creation of Smart Health, a joint venture that will lead the deployment of the Group's innovative centres in Saudi Arabia.

Based in Paris, Visiomed Group is listed on Euronext Growth (ALVMG). For more information, visit www.visiomed-group.com

CONTACTS

Jérôme FABREGUETTES LEIBFatou-Kiné N'DIAYE
Investor RelationsFinancial Press Relations
visiomed@actus.frfndiaye@actus.fr
Phone: +33 1 53 67 36 78Phone: +33 1 53 67 36 75

© Visiomed Group SA 2024. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: nWqdk5holG+Uy3GeZchpZmmXbWeXk2LJZmrLxWKcaZ2Uap6UyJllnJvIZnFkmW1q
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-83484-alvmg-cp-kafd-eng.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.